ClinicalTrials.Veeva

Menu

Pain Using Reduced Fluence Parameters in Photocoagulation for Diabetic Retinopathy.

A

Asociación para Evitar la Ceguera en México

Status and phase

Terminated
Phase 4

Conditions

Proliferative Diabetic Retinopathy

Treatments

Procedure: Retinal laser photocoagulation

Study type

Interventional

Funder types

Other

Identifiers

NCT00802269
APEC-032

Details and patient eligibility

About

The used of reduced fluence parameters for panretinal photocoagulation decreases pain as perceived by the patient, compared to traditional parameters.

Enrollment

25 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients 18 years or older, that signed informed consent
  • Proliferative diabetic retinopathy with indication for panretinal photocoagulation

Exclusion criteria

  • Previous retinal photocoagulation
  • Previous ocular surgical procedures
  • Ocular media opacities
  • History of trigeminal neuralgia
  • Chronic ocular pain
  • Depression under conductual or medical treatment

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

25 participants in 2 patient groups

Reduced Fluence Parameters
Experimental group
Description:
Eyes receiving retinal photocoagulation with reduced fluence parameters (time 20-50 msec, power 400-700 mW)
Treatment:
Procedure: Retinal laser photocoagulation
Traditional parameters
Active Comparator group
Description:
Eyes receiving retinal photocoagulation with traditional parameters (time 100-200 msec, power 200-400 mW)
Treatment:
Procedure: Retinal laser photocoagulation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems